# EDGAR Filing Document

**Accession Number:** 0001419248
**File Stem:** 0001290929-23-000008
**Filing Date:** 2023-2
**Character Count:** 7509
**Document Hash:** 1a49f250a9de9992355e8781ee053956
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001290929-23-000008.hdr.sgml**: 20230213

**ACCESSION NUMBER**: 0001290929-23-000008

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230210

**FILED AS OF DATE**: 20230213

**DATE AS OF CHANGE**: 20230213

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Wolf James G.
- **CENTRAL INDEX KEY:** 0001419248

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-09974
- **FILM NUMBER:** 23621604

**MAIL ADDRESS:**
- **STREET 1:** 105, FLYWAY DRIVE
- **CITY:** KIAWAH ISLAND
- **STATE:** SC
- **ZIP:** 29455
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ENZO BIOCHEM INC
- **CENTRAL INDEX KEY:** 0000316253
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MEDICAL LABORATORIES [8071]
- **IRS NUMBER:** 132866202
- **STATE OF INCORPORATION:** NY
- **FISCAL YEAR END:** 0731

**BUSINESS ADDRESS:**
- **STREET 1:** 60 EXECUTIVE BLVD
- **CITY:** FARMINGDALE
- **STATE:** NY
- **ZIP:** 11735
- **BUSINESS PHONE:** 5167555500

**MAIL ADDRESS:**
- **STREET 1:** ENZO BIOCHEM INC
- **STREET 2:** 60 EXECUTIVE BLVD
- **CITY:** FARMINGDALE
- **STATE:** NY
- **ZIP:** 11735

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[x] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Wolf James G.<br><sub>(Last) (First) (Middle)</sub><br>105, FLYWAY DRIVE<br><sub>(Street)</sub><br>KIAWAH ISLAND, SC 29455<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-10 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[ ] Officer (give title below) [X] Other (specify below)<br>_10% owner until 2/13/2023_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>ENZO BIOCHEM INC [ ENZ ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock, $0.01 par value | 2023-02-10 |  | P |  | 5000 | A | $1.29 | 4095000 | D |  |
| Common Stock, $0.01 par value | 2023-02-13 |  | P |  | 5000 | A | $1.285 | 4100000 | D |  |
| Common Stock, $0.01 par value | 2023-02-13 |  | P |  | 5000 | A | $1.29 | 115000 | I | See Footnote<sup>(1)</sup> |
| Common Stock, $0.01 par value |  |  |  |  |  |  |  | 308500 | I | See Footnote<sup>(2)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Long Call Option (right to buy) | $5 | 2023-02-13 |  | S |  |  | 324 | 2022-10-28 | 2023-04-21 | Common Stock, $0.01 par value | 32400 | $0.19 | 483 | D |  |
| Short Put Option (obligation to buy) | $2.5 | 2023-02-13 |  | S |  | 324 |  | 2023-02-13 | 2023-07-21 | Common Stock, $0.01 par value | 32400 | $1.01 | 324 | D |  |
| Short Put Option (obligation to buy) | $7.5 | 2023-02-13 |  | S |  |  | 750 | 2022-10-28 | 2023-04-21 | Common Stock, $0.01 par value | 75000 | $0.03 | 0 | D |  |
| Short Put Option (obligation to buy) | $2.5 | 2023-02-13 |  | S |  | 750 |  | 2023-02-13 | 2023-04-21 | Common Stock, $0.01 par value | 75000 | $1.12 | 2163 | D |  |
| Long Call Option (right to buy) | $2.5 |  |  |  |  |  |  | 2022-10-28 | 2023-04-21 | Common Stock, $0.01 par value | 100000 |  | 1000 | D |  |

---

### Footnotes:

(1) The transaction was completed in the name and for the benefit of the Reporting Person's sibling. The Reporting Person maintains a power of attorney granted by the Reporting Person's sibling with respect to these shares, including voting and dispositive power over the shares. The Reporting Person has no pecuniary interest in the shares and disclaims beneficial ownership of the securities held by his sibling. This report will not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

(2) The 308,500 shares owned indirectly by the Reporting Person include 116,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person, 22,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person's spouse and 170,500 shares owned directly by adult children of the Reporting Person.

**Signature:** James G. Wolf  
**Date:** 2023-02-13

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**